Search Results

An Interview With Alan T. Hirsch, MD

The Director of the Vascular Medicine Program at the University of Minnesota shares his thoughts on the role of exercise therapy in treating PAD, as well as spreading PAD awareness to the public, specifically, the underserved population of women.

Therapeutic Choice Is Quality Claudication Care

Exercise and claudication pharmacotherapies as the foundation to redefine conservative care.

By Mudassar Ahmed, MD; Sara Murray, MD; and Alan T. Hirsch, MD

Update From the CLI Global Society

Goals for 2020 and beyond.

By Jos C. van den Berg, MD, PhD; Jihad A. Mustapha, MD, FACC, FSCAI; and Richard F. Neville, MD, FACS, DFSVS, RCPSG (Hon)

LAUNCHING A NATIONAL VASCULAR EFFORT: ONE STEP AT A TIME

California PAD Task Force Committee

Michael R. Jaff, DO, discusses the PAD Task Force's recent initiative to increase awareness of peripheral artery disease.

Noninterventional and Medical PAD Management

By John R. Laird, Jr, MD with Michael R. Jaff, DO, FACP, FACC, FAHA

Chief Medical Editor's Page

More EVAR Options, But Also More Questions

By Ronald M. Fairman, MD, and Edward Y. Woo, MD

Evidence-Based CLI Therapies in 2016

The gap between real-world CLI practice and evidence-based therapies remains wide.

By Larry J. Diaz-Sandoval, MD; J.A. Mustapha, MD; and Fadi Saab, MD

The Renal Stenting Downturn

Why are we stenting less?

By George V. Moukarbel, MD, and Mark W. Burket, MD

Blunt Thoracic Aortic Injury: Current Issues and Endovascular Treatment Paradigms

The 2011 SVS TEVAR for BTAI clinical guidelines raised a number of unanswered questions. How have they been resolved since then?

By Joshua D. Adams, MD, and John A. Kern, MD

Endovascular Intervention of Iliofemoral Venous Thrombosis

Is there a role for percutaneous pharmacomechanical thrombectomy?

By Peter H. Lin, MD; Eric Peden, MD; Wei Zhou, MD; and Alan B. Lumsden, MD

High-Risk Pulmonary Embolism in Pregnancy: What Every Interventionalist Should Know

An overview of diagnosis, management, and the role of advanced therapies for high- and intermediate-high–risk pulmonary embolism.

By Vivian Bishay, MD

Optimizing Anti-Thrombotic Therapy After Catheter-Directed Interventions for DVT and PTS

Recommendations for anti-thrombotic and anti-inflammatory regimens after deep venous disease interventions based on patient presentation, comorbidities, and type of intervention.

By Dhara Kinariwala, MD; Aditya M. Sharma, MD, RPVI, FSVM; and Minhaj S. Khaja, MD, MBA, FSIR, FSVM